PDB Short entry for 3GW5 HEADER HYDROLASE/HYDROLASE INHIBITOR 31-MAR-09 3GW5 TITLE CRYSTAL STRUCTURE OF HUMAN RENIN COMPLEXED WITH A NOVEL INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: RENIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ANGIOTENSINOGENASE; COMPND 5 EC: 3.4.23.15; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: REN; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: HEK293; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PCDNA3.1 KEYWDS RENIN, ASPARTATE PROTEASE, HYPERTENSION, RENIN EXPRESSION, RENIN KEYWDS 2 INHIBITOR, ASPARTYL PROTEASE, CLEAVAGE ON PAIR OF BASIC RESIDUES, KEYWDS 3 DISEASE MUTATION, DISULFIDE BOND, GLYCOPROTEIN, HYDROLASE, MEMBRANE, KEYWDS 4 PROTEASE, SECRETED, ZYMOGEN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Z.WU,B.M.MCKEEVER REVDAT 5 06-SEP-23 3GW5 1 HETSYN REVDAT 4 29-JUL-20 3GW5 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE ATOM REVDAT 3 01-NOV-17 3GW5 1 REMARK REVDAT 2 13-JUL-11 3GW5 1 VERSN REVDAT 1 23-JUN-09 3GW5 0 JRNL AUTH C.M.TICE,Z.XU,J.YUAN,R.D.SIMPSON,S.T.CACATIAN,P.T.FLAHERTY, JRNL AUTH 2 W.ZHAO,J.GUO,A.ISHCHENKO,S.B.SINGH,Z.WU,B.B.SCOTT, JRNL AUTH 3 Y.BUKHTIYAROV,J.BERBAUM,J.MASON,R.PANEMANGALORE, JRNL AUTH 4 M.G.CAPPIELLO,D.MULLER,R.K.HARRISON,G.M.MCGEEHAN, JRNL AUTH 5 L.W.DILLARD,J.J.BALDWIN,D.A.CLAREMON JRNL TITL DESIGN AND OPTIMIZATION OF RENIN INHIBITORS: ORALLY JRNL TITL 2 BIOAVAILABLE ALKYL AMINES. JRNL REF BIOORG.MED.CHEM.LETT. V. 19 3541 2009 JRNL REFN ISSN 0960-894X JRNL PMID 19457666 JRNL DOI 10.1016/J.BMCL.2009.04.140 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 83.5 REMARK 3 NUMBER OF REFLECTIONS : 41273 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.210 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.800 REMARK 3 FREE R VALUE TEST SET COUNT : 2057 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 54269 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 76.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3000 REMARK 3 BIN FREE R VALUE : 0.4000 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 169 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5149 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 143 REMARK 3 SOLVENT ATOMS : 356 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.84 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00300 REMARK 3 B22 (A**2) : -0.11600 REMARK 3 B33 (A**2) : 0.11400 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.368 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.126 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.023 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.807 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : VTP25720.PAR REMARK 3 PARAMETER FILE 6 : GLYCEROL.PAR REMARK 3 PARAMETER FILE 7 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 8 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : VTP25720.TOP REMARK 3 TOPOLOGY FILE 6 : GLYCEROL.TOP REMARK 3 TOPOLOGY FILE 7 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 8 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3GW5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-APR-09. REMARK 100 THE DEPOSITION ID IS D_1000052381. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-OCT-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X8C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : SI (111) DOUBLE-CRYSTAL REMARK 200 MONOCHROMATOR REMARK 200 OPTICS : MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45324 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 83.7 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06900 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 76.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.57000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 3D91 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.66 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS-HCL, PH 7-8, 0.2 M REMARK 280 (NH4)2SO4, 18-26% PEG3550, 5 MG/ML RENIN, 1 MM INHIBITOR , VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 278K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.10150 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 74.77300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 48.53450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 74.77300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.10150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 48.53450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER B 166 REMARK 465 GLU B 167 REMARK 465 ASN B 168 REMARK 465 SER B 169 REMARK 465 GLN B 170 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 5 CG OD1 ND2 REMARK 470 ARG B 53 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 75 -66.27 -131.34 REMARK 500 ARG A 139 43.51 37.89 REMARK 500 GLN A 170 -102.45 -64.68 REMARK 500 SER A 171 102.03 46.56 REMARK 500 THR A 214 95.02 -65.95 REMARK 500 CYS A 221 -177.56 -172.52 REMARK 500 ALA A 299 46.46 -83.27 REMARK 500 ASN B 5 -29.11 79.83 REMARK 500 MET B 16 19.03 55.78 REMARK 500 ASN B 75 -42.80 -134.96 REMARK 500 ILE B 196 -72.62 -58.82 REMARK 500 ASN B 332 67.29 39.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 SER B 171 LEU B 172 149.91 REMARK 500 REMARK 500 REMARK: NULL DBREF 3GW5 A 4 340 UNP P00797 RENI_HUMAN 70 406 DBREF 3GW5 B 4 340 UNP P00797 RENI_HUMAN 70 406 SEQRES 1 A 337 GLY ASN THR THR SER SER VAL ILE LEU THR ASN TYR MET SEQRES 2 A 337 ASP THR GLN TYR TYR GLY GLU ILE GLY ILE GLY THR PRO SEQRES 3 A 337 PRO GLN THR PHE LYS VAL VAL PHE ASP THR GLY SER SER SEQRES 4 A 337 ASN VAL TRP VAL PRO SER SER LYS CYS SER ARG LEU TYR SEQRES 5 A 337 THR ALA CYS VAL TYR HIS LYS LEU PHE ASP ALA SER ASP SEQRES 6 A 337 SER SER SER TYR LYS HIS ASN GLY THR GLU LEU THR LEU SEQRES 7 A 337 ARG TYR SER THR GLY THR VAL SER GLY PHE LEU SER GLN SEQRES 8 A 337 ASP ILE ILE THR VAL GLY GLY ILE THR VAL THR GLN MET SEQRES 9 A 337 PHE GLY GLU VAL THR GLU MET PRO ALA LEU PRO PHE MET SEQRES 10 A 337 LEU ALA GLU PHE ASP GLY VAL VAL GLY MET GLY PHE ILE SEQRES 11 A 337 GLU GLN ALA ILE GLY ARG VAL THR PRO ILE PHE ASP ASN SEQRES 12 A 337 ILE ILE SER GLN GLY VAL LEU LYS GLU ASP VAL PHE SER SEQRES 13 A 337 PHE TYR TYR ASN ARG ASP SER GLU ASN SER GLN SER LEU SEQRES 14 A 337 GLY GLY GLN ILE VAL LEU GLY GLY SER ASP PRO GLN HIS SEQRES 15 A 337 TYR GLU GLY ASN PHE HIS TYR ILE ASN LEU ILE LYS THR SEQRES 16 A 337 GLY VAL TRP GLN ILE GLN MET LYS GLY VAL SER VAL GLY SEQRES 17 A 337 SER SER THR LEU LEU CYS GLU ASP GLY CYS LEU ALA LEU SEQRES 18 A 337 VAL ASP THR GLY ALA SER TYR ILE SER GLY SER THR SER SEQRES 19 A 337 SER ILE GLU LYS LEU MET GLU ALA LEU GLY ALA LYS LYS SEQRES 20 A 337 ARG LEU PHE ASP TYR VAL VAL LYS CYS ASN GLU GLY PRO SEQRES 21 A 337 THR LEU PRO ASP ILE SER PHE HIS LEU GLY GLY LYS GLU SEQRES 22 A 337 TYR THR LEU THR SER ALA ASP TYR VAL PHE GLN GLU SER SEQRES 23 A 337 TYR SER SER LYS LYS LEU CYS THR LEU ALA ILE HIS ALA SEQRES 24 A 337 MET ASP ILE PRO PRO PRO THR GLY PRO THR TRP ALA LEU SEQRES 25 A 337 GLY ALA THR PHE ILE ARG LYS PHE TYR THR GLU PHE ASP SEQRES 26 A 337 ARG ARG ASN ASN ARG ILE GLY PHE ALA LEU ALA ARG SEQRES 1 B 337 GLY ASN THR THR SER SER VAL ILE LEU THR ASN TYR MET SEQRES 2 B 337 ASP THR GLN TYR TYR GLY GLU ILE GLY ILE GLY THR PRO SEQRES 3 B 337 PRO GLN THR PHE LYS VAL VAL PHE ASP THR GLY SER SER SEQRES 4 B 337 ASN VAL TRP VAL PRO SER SER LYS CYS SER ARG LEU TYR SEQRES 5 B 337 THR ALA CYS VAL TYR HIS LYS LEU PHE ASP ALA SER ASP SEQRES 6 B 337 SER SER SER TYR LYS HIS ASN GLY THR GLU LEU THR LEU SEQRES 7 B 337 ARG TYR SER THR GLY THR VAL SER GLY PHE LEU SER GLN SEQRES 8 B 337 ASP ILE ILE THR VAL GLY GLY ILE THR VAL THR GLN MET SEQRES 9 B 337 PHE GLY GLU VAL THR GLU MET PRO ALA LEU PRO PHE MET SEQRES 10 B 337 LEU ALA GLU PHE ASP GLY VAL VAL GLY MET GLY PHE ILE SEQRES 11 B 337 GLU GLN ALA ILE GLY ARG VAL THR PRO ILE PHE ASP ASN SEQRES 12 B 337 ILE ILE SER GLN GLY VAL LEU LYS GLU ASP VAL PHE SER SEQRES 13 B 337 PHE TYR TYR ASN ARG ASP SER GLU ASN SER GLN SER LEU SEQRES 14 B 337 GLY GLY GLN ILE VAL LEU GLY GLY SER ASP PRO GLN HIS SEQRES 15 B 337 TYR GLU GLY ASN PHE HIS TYR ILE ASN LEU ILE LYS THR SEQRES 16 B 337 GLY VAL TRP GLN ILE GLN MET LYS GLY VAL SER VAL GLY SEQRES 17 B 337 SER SER THR LEU LEU CYS GLU ASP GLY CYS LEU ALA LEU SEQRES 18 B 337 VAL ASP THR GLY ALA SER TYR ILE SER GLY SER THR SER SEQRES 19 B 337 SER ILE GLU LYS LEU MET GLU ALA LEU GLY ALA LYS LYS SEQRES 20 B 337 ARG LEU PHE ASP TYR VAL VAL LYS CYS ASN GLU GLY PRO SEQRES 21 B 337 THR LEU PRO ASP ILE SER PHE HIS LEU GLY GLY LYS GLU SEQRES 22 B 337 TYR THR LEU THR SER ALA ASP TYR VAL PHE GLN GLU SER SEQRES 23 B 337 TYR SER SER LYS LYS LEU CYS THR LEU ALA ILE HIS ALA SEQRES 24 B 337 MET ASP ILE PRO PRO PRO THR GLY PRO THR TRP ALA LEU SEQRES 25 B 337 GLY ALA THR PHE ILE ARG LYS PHE TYR THR GLU PHE ASP SEQRES 26 B 337 ARG ARG ASN ASN ARG ILE GLY PHE ALA LEU ALA ARG MODRES 3GW5 ASN A 75 ASN GLYCOSYLATION SITE MODRES 3GW5 ASN B 75 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET NAG C 2 14 HET 72X A 400 35 HET GOL A 500 6 HET GOL A 501 6 HET GOL A 502 6 HET GOL A 503 6 HET CL A 700 1 HET 72X B 400 35 HET NAG B 600 14 HET GOL B 504 6 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM 72X (3R)-3-[(1S)-1-(3-CHLOROPHENYL)-1-HYDROXY-5- HETNAM 2 72X METHOXYPENTYL]-N-{(1S)-2-CYCLOHEXYL-1-[(METHYLAMINO) HETNAM 3 72X METHYL]ETHYL}PIPERIDINE-1-CARBOXAMIDE HETNAM GOL GLYCEROL HETNAM CL CHLORIDE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 NAG 3(C8 H15 N O6) FORMUL 4 72X 2(C28 H46 CL N3 O3) FORMUL 5 GOL 5(C3 H8 O3) FORMUL 9 CL CL 1- FORMUL 13 HOH *356(H2 O) HELIX 1 1 TYR A 55 VAL A 59 5 5 HELIX 2 2 ASP A 65 SER A 69 5 5 HELIX 3 3 PRO A 115 MET A 120 1 6 HELIX 4 4 PHE A 132 VAL A 140 5 9 HELIX 5 5 PRO A 142 GLY A 151 1 10 HELIX 6 6 ASP A 182 GLN A 184 5 3 HELIX 7 7 SER A 235 GLY A 247 1 13 HELIX 8 8 ASN A 260 LEU A 265 5 6 HELIX 9 9 THR A 280 VAL A 285 1 6 HELIX 10 10 GLY A 316 ARG A 321 1 6 HELIX 11 11 THR B 56 HIS B 61 1 6 HELIX 12 12 ASP B 65 SER B 69 5 5 HELIX 13 13 PRO B 115 MET B 120 1 6 HELIX 14 14 PHE B 132 VAL B 140 5 9 HELIX 15 15 PRO B 142 GLN B 150 1 9 HELIX 16 16 ASP B 182 GLN B 184 5 3 HELIX 17 17 SER B 235 GLY B 247 1 13 HELIX 18 18 ASN B 260 LEU B 265 5 6 HELIX 19 19 THR B 280 VAL B 285 1 6 HELIX 20 20 GLY B 316 ARG B 321 1 6 SHEET 1 A 9 LYS A 73 TYR A 83 0 SHEET 2 A 9 GLY A 86 VAL A 99 -1 O GLN A 94 N LYS A 73 SHEET 3 A 9 GLN A 19 ILE A 26 -1 N GLY A 25 O THR A 98 SHEET 4 A 9 SER A 8 TYR A 15 -1 N THR A 13 O TYR A 21 SHEET 5 A 9 GLY A 174 LEU A 178 -1 O LEU A 178 N SER A 8 SHEET 6 A 9 VAL A 157 TYR A 162 -1 N TYR A 161 O GLN A 175 SHEET 7 A 9 PHE A 323 ASP A 328 -1 O PHE A 327 N PHE A 158 SHEET 8 A 9 ARG A 333 ALA A 339 -1 O GLY A 335 N GLU A 326 SHEET 9 A 9 TYR A 186 ASN A 194 -1 N ILE A 193 O ILE A 334 SHEET 1 B13 LYS A 73 TYR A 83 0 SHEET 2 B13 GLY A 86 VAL A 99 -1 O GLN A 94 N LYS A 73 SHEET 3 B13 ILE A 102 GLU A 113 -1 O VAL A 104 N ILE A 97 SHEET 4 B13 VAL A 44 PRO A 47 1 N VAL A 44 O GLY A 109 SHEET 5 B13 GLY A 126 GLY A 129 -1 O VAL A 127 N TRP A 45 SHEET 6 B13 GLN A 31 ASP A 38 1 N VAL A 36 O VAL A 128 SHEET 7 B13 GLN A 19 ILE A 26 -1 N ILE A 26 O GLN A 31 SHEET 8 B13 SER A 8 TYR A 15 -1 N THR A 13 O TYR A 21 SHEET 9 B13 GLY A 174 LEU A 178 -1 O LEU A 178 N SER A 8 SHEET 10 B13 VAL A 157 TYR A 162 -1 N TYR A 161 O GLN A 175 SHEET 11 B13 PHE A 323 ASP A 328 -1 O PHE A 327 N PHE A 158 SHEET 12 B13 ARG A 333 ALA A 339 -1 O GLY A 335 N GLU A 326 SHEET 13 B13 TYR A 186 ASN A 194 -1 N ILE A 193 O ILE A 334 SHEET 1 C 3 GLN A 202 MET A 205 0 SHEET 2 C 3 CYS A 221 VAL A 225 -1 O CYS A 221 N MET A 205 SHEET 3 C 3 TRP A 313 LEU A 315 1 O LEU A 315 N LEU A 224 SHEET 1 D 4 SER A 213 LEU A 216 0 SHEET 2 D 4 GLY A 207 VAL A 210 -1 N VAL A 208 O LEU A 216 SHEET 3 D 4 ILE A 268 LEU A 272 -1 O HIS A 271 N GLY A 207 SHEET 4 D 4 LYS A 275 LEU A 279 -1 O TYR A 277 N PHE A 270 SHEET 1 E 2 ILE A 232 GLY A 234 0 SHEET 2 E 2 ILE A 300 ALA A 302 1 O HIS A 301 N ILE A 232 SHEET 1 F 3 LYS A 249 LYS A 250 0 SHEET 2 F 3 TYR A 255 LYS A 258 -1 O VAL A 256 N LYS A 249 SHEET 3 F 3 LEU A 295 THR A 297 -1 O CYS A 296 N VAL A 257 SHEET 1 G 9 GLU B 78 TYR B 83 0 SHEET 2 G 9 GLY B 86 VAL B 99 -1 O GLY B 90 N LEU B 79 SHEET 3 G 9 GLN B 19 ILE B 26 -1 N GLY B 25 O THR B 98 SHEET 4 G 9 SER B 8 TYR B 15 -1 N TYR B 15 O GLN B 19 SHEET 5 G 9 GLY B 174 LEU B 178 -1 O LEU B 178 N SER B 8 SHEET 6 G 9 VAL B 157 TYR B 162 -1 N TYR B 161 O GLN B 175 SHEET 7 G 9 PHE B 323 ASP B 328 -1 O PHE B 327 N PHE B 158 SHEET 8 G 9 ARG B 333 ALA B 339 -1 O ARG B 333 N ASP B 328 SHEET 9 G 9 TYR B 186 ASN B 194 -1 N ILE B 193 O ILE B 334 SHEET 1 H13 GLU B 78 TYR B 83 0 SHEET 2 H13 GLY B 86 VAL B 99 -1 O GLY B 90 N LEU B 79 SHEET 3 H13 ILE B 102 GLU B 113 -1 O GLU B 110 N PHE B 91 SHEET 4 H13 VAL B 44 PRO B 47 1 N VAL B 44 O GLY B 109 SHEET 5 H13 GLY B 126 GLY B 129 -1 O VAL B 127 N TRP B 45 SHEET 6 H13 GLN B 31 ASP B 38 1 N VAL B 36 O VAL B 128 SHEET 7 H13 GLN B 19 ILE B 26 -1 N ILE B 26 O GLN B 31 SHEET 8 H13 SER B 8 TYR B 15 -1 N TYR B 15 O GLN B 19 SHEET 9 H13 GLY B 174 LEU B 178 -1 O LEU B 178 N SER B 8 SHEET 10 H13 VAL B 157 TYR B 162 -1 N TYR B 161 O GLN B 175 SHEET 11 H13 PHE B 323 ASP B 328 -1 O PHE B 327 N PHE B 158 SHEET 12 H13 ARG B 333 ALA B 339 -1 O ARG B 333 N ASP B 328 SHEET 13 H13 TYR B 186 ASN B 194 -1 N ILE B 193 O ILE B 334 SHEET 1 I 4 SER B 213 LEU B 216 0 SHEET 2 I 4 GLN B 202 VAL B 210 -1 N VAL B 210 O SER B 213 SHEET 3 I 4 ILE B 268 LEU B 272 -1 O HIS B 271 N GLY B 207 SHEET 4 I 4 LYS B 275 LEU B 279 -1 O LEU B 279 N ILE B 268 SHEET 1 J 4 SER B 213 LEU B 216 0 SHEET 2 J 4 GLN B 202 VAL B 210 -1 N VAL B 210 O SER B 213 SHEET 3 J 4 CYS B 221 VAL B 225 -1 O CYS B 221 N MET B 205 SHEET 4 J 4 TRP B 313 LEU B 315 1 O LEU B 315 N LEU B 224 SHEET 1 K 2 ILE B 232 GLY B 234 0 SHEET 2 K 2 ILE B 300 ALA B 302 1 O HIS B 301 N ILE B 232 SHEET 1 L 3 LYS B 249 LYS B 250 0 SHEET 2 L 3 TYR B 255 LYS B 258 -1 O VAL B 256 N LYS B 249 SHEET 3 L 3 LEU B 295 THR B 297 -1 O CYS B 296 N VAL B 257 SSBOND 1 CYS A 51 CYS A 58 1555 1555 2.40 SSBOND 2 CYS A 217 CYS A 221 1555 1555 2.62 SSBOND 3 CYS A 259 CYS A 296 1555 1555 2.63 SSBOND 4 CYS B 51 CYS B 58 1555 1555 2.75 SSBOND 5 CYS B 217 CYS B 221 1555 1555 2.69 SSBOND 6 CYS B 259 CYS B 296 1555 1555 2.63 LINK ND2 ASN A 75 C1 NAG C 1 1555 1555 1.45 LINK ND2 ASN B 75 C1 NAG B 600 1555 1555 1.45 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.39 CISPEP 1 THR A 28 PRO A 29 0 -5.58 CISPEP 2 LEU A 117 PRO A 118 0 7.31 CISPEP 3 PRO A 307 PRO A 308 0 2.80 CISPEP 4 GLY A 310 PRO A 311 0 -1.17 CISPEP 5 THR B 28 PRO B 29 0 -5.71 CISPEP 6 LEU B 117 PRO B 118 0 11.66 CISPEP 7 PRO B 307 PRO B 308 0 0.51 CISPEP 8 GLY B 310 PRO B 311 0 -1.24 CRYST1 54.203 97.069 149.546 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018449 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010302 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006687 0.00000